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1. Introduction
Expression of the gene encoding the major surfac-
tant protein, surfactant protein-A (SP-A), is essen-
tially lung-speci¢c, occurs primarily in alveolar type
II cells, and is developmentally and hormonally regu-
lated in fetal lung. SP-A gene transcription is initi-
ated in fetal lung after approx. 70% of gestation is
completed and reaches maximal levels just prior to
birth [1]. SP-A gene expression in fetal lung appears
to be under multifactorial control; we have observed
that glucocorticoids and hormones and factors that
increase cyclic AMP formation serve important roles
in the regulation of SP-A gene expression. Whereas
cyclic AMP acts to increase SP-A expression at the
level of gene transcription, glucocorticoid actions are
far more complex, may be indirect, and appear to
involve transcriptional and posttranscriptional mech-
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anisms. In this review, we ¢rst will consider the struc-
ture of the SP-A gene(s) and tissue/cell-speci¢c, de-
velopmental and multifactorial regulation of expres-
sion. We then will review recent studies to char-
acterize the response elements that mediate basal
and cyclic AMP induction of SP-A gene transcrip-
tion in type II cells, as well as the transcription fac-
tors that bind to these elements and our current
understanding of the mechanisms involved in their
regulation.
2. Structural properties of the SP-A gene
SP-A exists as a single copy gene in rats [2], mice
[3], and rabbits [4,5]; however, the genomes of hu-
mans [6,7] and baboons [8] have been found to con-
tain two highly similar SP-A gene products, SP-A1
and SP-A2. The human (h)SP-A genes are 95.6%
similar at the amino acid level (238 out of 249 amino
acids are identical), but the genes di¡er in their exon-
intron organization. Human SP-A2 mRNA tran-
scripts are always comprised of sequences contained
within six exons, while the majority of transcripts of
the hSP-A1 gene are comprised of sequences con-
tained within ¢ve exons; the alternatively spliced
exon present in all hSP-A2 mRNA transcripts enco-
des an additional 5P-untranslated sequence [7,9]. The
SP-A proteins encoded by the two baboon (b)SP-A
genes have a higher degree of similarity (97.2% ami-
no acid identity; 242 out of 249 amino acids are
identical) than that which exists between the two
human SP-A proteins [8]. By comparison of 5P-£ank-
ing and intronic sequences of the bSP-A genes with
those of the human, we found one to be more similar
to hSP-A1 (bSP-A1) and the other to be more similar
to hSP-A2 (bSP-A2).
The hSP-A1 and hSP-A2 genes, together with a
truncated hSP-A pseudogene [10] and the genes en-
coding hSP-D and the mannose-binding protein C-
type lectins are localized to human chromosome
10q22-q23 [11]. The genes encoding hSP-A2 and
hSP-D are estimated to be 40 kb and 120 kb 5P to
hSP-A1, respectively, while the hSP-A pseudogene
lies between hSP-A1 and hSP-A2 [12]. Interestingly,
the hSP-A1 and hSP-A2 genes appear to be in a
‘head to head’ conformation, suggesting that they
may share certain upstream regulatory regions [12].
3. Regulation of SP-A gene expression
3.1. Tissue/cell-speci¢c and developmental regulation
SP-A gene expression is essentially lung-speci¢c;
mRNA transcripts are detected primarily in type II
cells and in non-ciliated bronchioalveolar epithelial
(Clara) cells [13,14]. In second trimester human fetal
lung, SP-A mRNA and protein have also been de-
tected in non-mucous tracheal glands, in bronchial
glands, and in isolated cells of conducting airway
epithelium [15]. Low levels of SP-A expression have
been reported in intestinal epithelium [16] and in a
phospholipid-rich layer recovered from rat and hu-
man colon [17].
Transcription of the SP-A gene is initiated in fetal
lung after approx. 70% of gestation is completed and
reaches maximal levels just prior to birth [1]. Devel-
opmental regulation of SP-A gene expression is more
closely associated with the induction of surfactant
glycerophospholipid synthesis and appearance of
identi¢able type II cells than is the developmental
regulation of genes encoding SP-B, SP-C and SP-D.
SP-A gene transcription is ¢rst discernible in fetal
rabbit lung tissue on day 24 of gestation and reaches
maximum levels by day 28 [18]. In situ hybridization
analysis of fetal rabbit lung tissue at di¡erent devel-
opmental stages revealed that SP-A mRNA is ¢rst
detectable in type II cells on day 26 of the 31 day
gestation period; by day 31 of gestation, SP-A
mRNA transcripts are also detectable in Clara cells
[13,14]. The developmental induction of SP-A gene
transcription is associated with the appearance of
SP-A mRNA and protein on day 26 [4,19,20], just
prior to the time at which augmented surfactant glyc-
erophospholipid synthesis occurs. In fetal baboons,
SP-A mRNA levels, which are barely detectable in
fetal lung at midgestation (92 days), are increased
approx. 4-fold between 125 and 140 days gestation,
approx. 7-fold between 140 and 160 days, and ap-
prox. 1.5-fold between 160 and 174 days gestation
(term=185 days) [21]. In human fetal lung tissue,
SP-A mRNA and protein are undetectable at 16^20
weeks of gestation [22,23]. Immunoreactive SP-A
protein is detectable in amniotic £uid at 30 weeks
of gestation and is increased further during develop-
ment in association with the increase in the L/S ratio
in amniotic £uid [24].
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We have observed that the human and baboon
SP-A1 and SP-A2 genes appear to be di¡erentially
regulated during development. In lung tissue from a
28 week gestation human newborn, only hSP-A1
mRNA transcripts were evident, and in midgestation
human fetal lung explants cultured in control me-
dium, levels of hSP-A1 mRNA transcripts were 2^
3-fold greater than those of hSP-A2 [25]. By contrast,
in adult human lung tissue the ratio of hSP-A2 to
hSP-A1 was found to be 3:1 [25]. These ¢ndings
suggest that expression of the hSP-A2 gene relative
to hSP-A1 increases during development. Similarly,
expression of the bSP-A2 gene appears to be induced
to high levels at a later time in gestation than is bSP-
A1 [26]. Our ¢ndings regarding the relative levels of
hSP-A1 to hSP-A2 in adult human lung di¡er from
those of Karinch et al. [27] who reported that hSP-
A1 mRNA transcripts predominate over those of
hSP-A2. The reason for the discrepancy in our ¢nd-
ings is not known.
3.2. Regulation by hormones and factors
SP-A gene expression in fetal lung tissues of vari-
ous species has been found to be regulated by a
variety of hormones and factors, including retinoids,
insulin, growth factors and cytokines, glucocorticoids
and agents that increase formation of cyclic AMP
(see [28] for review). In the interest of space, we
will restrict this review to a consideration of the ef-
fects of cyclic AMP and glucocorticoids on the reg-
ulation of SP-A gene expression. Many of our stud-
ies of SP-A gene regulation have been carried out
using organ culture of lung tissues from midgestation
human abortuses, 19 or 21 day fetal rabbits and 125
day gestational age fetal baboons. The fetal lung ex-
plants di¡erentiate spontaneously when placed in or-
gan culture in serum-free, de¢ned medium [29,30].
Before culture, the tissue is comprised of small ducts
surrounded by abundant connective tissue; the duct-
ular epithelial cells are columnar, ¢lled with cytoplas-
mic glycogen, and contain no lamellar bodies. Within
4 days of organ culture, the ducts enlarge, the
amount of connective tissue is decreased, and the
epithelium di¡erentiates into recognizable type II
cells containing lamellar bodies [29]. These changes
in morphology are associated with an induction
of the levels of SP-A mRNA and protein, which
are undetectable in the fetal lung prior to culture
[19,23].
3.2.1. E¡ects of hormones and factors that increase
cyclic AMP
We have found that cyclic AMP analogues en-
hance the rate of type II cell di¡erentiation and of
enlargement of the prealveolar ducts in midgestation
human fetal lung explants [31]. Cyclic AMP also in-
creases expression of the SP-A gene in rabbit, ba-
boon and human fetal lung tissue in organ culture.
By contrast, the rat [32] and mouse (J.L. Alcorn,
C.R. Mendelson, unpublished data) SP-A genes do
not appear to be responsive to cyclic AMP. Since we
have found that cyclic AMP has a pronounced e¡ect
to stimulate promoter activity of the human, rabbit
and baboon SP-A genes in transfected rat type II
cells in primary culture, while expression of the en-
dogenous rat SP-A gene is una¡ected by cyclic AMP
treatment [33^35], it is likely that di¡erences in cyclic
AMP responsiveness are due to species-speci¢c dif-
ferences in cis-acting regulatory elements, rather than
in trans-acting factors. Interestingly, in midgestation
human fetal lung explants, the hSP-A2 gene appears
to be far more responsive to the inductive e¡ects of
cyclic AMP analogues than is the gene encoding
hSP-A1 [25,36], whereas both bSP-A1 and bSP-A2
genes appear to be equivalently induced by cyclic
AMP treatment [26]. Since the sequences of the
bSP-A1 and bSP-A2 genes are more similar to each
other than those of hSP-A1 and hSP-A2 [8], it is
likely that during evolution, divergence of the hSP-
A1 gene resulted in a decrease in its responsiveness to
cyclic AMP.
The hormones and factors that act by endocrine,
paracrine or autocrine mechanisms to increase cyclic
AMP formation by type II cells in fetal lung during
development have not been de¢ned. L-Adrenoceptors
have been identi¢ed in fetal lung tissues [37], and the
concentration of L-adrenoceptors, as well as respon-
siveness of adenylyl cyclase to catecholamines, have
been found to increase in fetal rabbit lung tissue with
advancing gestational age [38]. The ¢ndings that nor-
epinephrine levels in human fetal plasma increase
during late gestation and that administration of L-
adrenergic agonists as tocolytic agents to women in
preterm labor results in a decreased incidence of
RDS in their prematurely born infants are further
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suggestive of a role of the adrenergic system in fetal
lung maturation and surfactant synthesis (see [1] for
review).
We have found that human fetal lung in organ
culture produces large quantities of prostaglandin
E2 (PGE2) and prostacyclin (PGI2) [39]. Treatment
of the human fetal lung explants with the cyclooxy-
genase inhibitor indomethacin markedly reduced cy-
clic AMP formation by the cultured fetal lung tissue
and blocked the spontaneous induction of SP-A gene
expression. Indomethacin also signi¢cantly inhibited
the spontaneous increase in alveolar lumenal volume
density and reduced the number of lamellar bodies in
type II cells [39]. The ¢ndings that treatment of the
cultured fetal lung tissue with PGE2 increased cyclic
AMP formation, and that PGE2 or Bt2cAMP could
overcome the inhibitory e¡ect of indomethacin on
SP-A gene expression are suggestive that endogenous
prostaglandins acting through cyclic AMP may serve
a role in the spontaneous di¡erentiation of midges-
tation human fetal lung in culture [39].
3.2.2. E¡ects of oxygen
Spontaneous di¡erentiation of cultured human fe-
tal lung explants and cyclic AMP induction of SP-A
gene expression are dependent upon the content of
atmospheric oxygen in the culture environment [40].
When fetal lung explants were cultured in an atmos-
phere containing 1% oxygen (as compared to the
oxygen content of 20%, which exists in our standard
culture environment), they failed to di¡erentiate and
no induction of SP-A gene expression was apparent.
Furthermore, at 1% oxygen, no inductive e¡ects of
Bt2cAMP on morphologic di¡erentiation or on SP-A
gene expression were apparent. These inhibitory ef-
fects of low oxygen were reversed when the tissues
were transferred to a 20% oxygen-containing envi-
ronment. The e¡ects of atmospheric oxygen on SP-
A gene expression and on morphologic development
were found to be concentration-dependent; the stim-
ulatory e¡ects of cyclic AMP were observed only at
oxygen concentrations v 10% [40]. These ¢ndings
suggest that oxygen plays a permissive role in the
spontaneous morphological and biochemical di¡er-
entiation of human fetal lung in culture. We suggest
that the increase in oxygen delivery to presumptive
alveolar epithelial cells, which occurs with increased
vascularization of the developing lung, may serve to
increase responsiveness of these cells to the inductive
e¡ects of intracellular cyclic AMP produced in re-
sponse to a number of regulatory factors, including
catecholamines and prostaglandins.
3.2.3. E¡ects of glucocorticoids
Glucocorticoids appear to have complex e¡ects on
SP-A gene expression that are species-speci¢c and
dependent upon the gestational age of the fetal
lung tissue. The e¡ects of glucocorticoids are medi-
ated both at transcriptional and posttranscriptional
levels. In studies using midgestation human fetal lung
explants, we observed that dexamethasone (Dex)
caused a dose-dependent induction of SP-A gene
transcription and acted synergistically with Bt2cAMP
[41,42]; however, Dex caused a dose-dependent de-
crease in the levels of SP-A mRNA and protein and
antagonized the stimulatory e¡ect of Bt2cAMP on
SP-A mRNA and protein levels [43]. This is due to
an action of glucocorticoids to decrease SP-A
mRNA stability [41,42]. The inhibitory e¡ects of
Dex on SP-A mRNA stability were found to be
dose-dependent, completely reversible and blocked
by the glucocorticoid receptor antagonist RU486
[42]. In human fetal lung explants cultured in the
presence of Bt2cAMP, we found that Dex had a
marked e¡ect to reduce the levels of hSP-A2
mRNA, whereas the levels of hSP-A1 mRNA were
largely una¡ected by glucocorticoid treatment [25].
By contrast, Kumar and Snyder [36] reported that
in human fetal lung explants cultured in the presence
of Dex alone, there was an equivalent reduction in
the levels hSP-A1 and hSP-A2 mRNA transcripts.
Similar to ¢ndings using midgestation human fetal
lung, in lung explants from 90, 125, and 140 day
gestational age fetal baboons (term = 184 days), Dex
also caused a dose-dependent inhibition of SP-A
mRNA levels and antagonized the stimulatory e¡ect
of Bt2cAMP [21]. By contrast, SP-A mRNA, which
was found to be present at relatively high levels in
lung tissues of 160 and 174 day fetal baboons prior
to culture, was relatively una¡ected by incubation
with Bt2cAMP or Dex [21]. These ¢ndings suggest
that with increased lung maturation and the devel-
opmental induction of SP-A gene expression, there is
a decrease in responsiveness of the fetal lung to the
stimulatory e¡ects of cyclic AMP and the inhibitory
e¡ects of glucocorticoids on SP-A gene expression.
BBADIS 61767 29-10-98
C.R. Mendelson et al. / Biochimica et Biophysica Acta 1408 (1998) 132^149 135
In fetal rabbit lung, glucocorticoids have both in-
hibitory and stimulatory e¡ects on SP-A gene tran-
scription that appear to be related to the state of
di¡erentiation of the fetal lung tissue. Treatment of
lung explants from 21 day fetal rabbits with cortisol
or Dex (1037 M) caused an acute (6^24 h) inhibition
of SP-A gene transcription and reduced the magni-
tude of the stimulatory e¡ect of Bt2cAMP [18]. How-
ever, after 48^72 h of incubation, a stimulatory e¡ect
of glucocorticoid was observed and there was found
to be an additive e¡ect with Bt2cAMP on SP-A gene
transcription [18]. We suggest that these di¡erentia-
tion-related changes in glucocorticoid responsiveness
may be related to changes in chromatin structure
accompanying cellular di¡erentiation which could
render glucocorticoid-responsive enhancer (GRE) el-
ements accessible to trans-acting factors (e.g. the glu-
cocorticoid receptor). Maternal administration of
synthetic glucocorticoids has also been reported to
increase SP-A gene expression in lung tissues of fetal
rabbits [44] and rats [45]. In rats, Dex appears to
have the greatest e¡ect to stimulate SP-A gene ex-
pression during the glandular phase of lung develop-
ment [45].
Despite the well-documented actions of glucocorti-
coids on SP-A gene expression in cultured lung tis-
sues and in animals, the physiological role of endog-
enous glucocorticoids in the regulation of SP-A gene
expression in fetal lung is unclear in regard to ¢nd-
ings in mice homozygous for targeted disruption of
the glucocorticoid receptor (GR) gene [46]. GR 3/3
mice die within several hours of birth as a result of
respiratory failure caused by atelectatic underdevel-
oped lungs [46]. The lack of GR was suggested to
impair development of the terminal bronchioles and
alveoli beyond embryonic day (E)15.5. Of note, how-
ever, was the ¢nding in lung tissues of newborn GR
3/3 mice of comparable numbers of alveolar type II
cells and apparently normal levels of mRNA encod-
ing SP-A, SP-B and SP-C, as compared to heterozy-
gous or wild-type animals [46]. It was suggested that
the respiratory failure of the GR 3/3 neonates was
not due to inadequate development of the surfactant
system, but rather to decreased expression of the
glucocorticoid-responsive amiloride-sensitive epithe-
lial Na channel (ENaC), which normally is induced
in alveolar epithelium after E17 in mouse and is es-
sential for lung liquid clearance [47]. Since study of
the lungs of the GR 3/3 mice did not include anal-
ysis of surfactant synthesis or composition, it re-
mains possible that perinatal mortality of these ani-
mals may have been due, in part, to inadequate
surfactant glycerophospholipid synthesis and/or se-
cretion.
4. Mechanisms involved in the regulation of SP-A
gene expression
As discussed above, expression of the human, ba-
boon and rabbit SP-A genes are markedly induced by
cyclic AMP. In studies using cultured human [41,42]
and rabbit [18] fetal lung, we observed that this e¡ect
of cyclic AMP is exerted at the level of SP-A gene
transcription. To functionally de¢ne the cis-acting el-
ements required for cyclic AMP induction of SP-A
transcriptional activity, fusion genes were constructed
comprised of various amounts of 5P-£anking DNA
from the human, rabbit and baboon SP-A genes
linked to the human growth hormone (hGH) struc-
tural gene, as reporter, and introduced into cultured
type II cells. In consideration of the fact that the SP-
A gene is expressed in a lung-speci¢c manner and
selectively in type II cells, we reasoned that such stud-
ies should be carried out using type II cells in primary
culture that have maintained their phenotypic proper-
ties, particularly with regard to SP-A gene expression.
To accomplish this, we devised a method for primary
monolayer culture of type II cells isolated from rat,
rabbit, mouse and human fetal lung [48]. The lung
cells contain osmiophilic lamellar inclusions with
the ultrastructural characteristics of lamellar bodies
and continue to express the SP-A gene at elevated
levels for up to 3 weeks of culture [48]. Since these
cells are resistant to conventional methods of DNA
transfection, the fusion genes were incorporated into
a replication-defective human adenovirus vector
(Ad5) and introduced into the type II cells by infec-
tion [33]. This results in highly e⁄cient and reprodu-
cible transfection of fusion gene constructs into the
primary cultures of type II cells. SP-A promoter ac-
tivity is analyzed by radioimmunoassay of hGH pro-
tein secreted into the culture medium over each 24 h
period for 5 days. A schematic diagram of the meth-
od for functional mapping of the 5P-£anking region
of the SP-A gene is shown in Fig. 1.
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4.1. Characterization of response elements within
the 5P-£anking regions of the human, rabbit
and baboon SP-A genes and analysis of their
binding proteins
The ¢ndings of deletion mapping and mutagenesis
studies of the human, rabbit and baboon SP-A gene
5P-£anking sequences indicate that basal and cyclic
AMP induced expression of SP-A promoter activity
in lung type II cells are critically dependent upon the
cooperative interactions of transcription factors
bound to at least four regulatory elements which lie
within approx. 400 bp upstream from the SP-A gene
transcription initiation site. These include an E
box-like motif (proximal binding element, PBE) [49,
50], a cyclic AMP-response element-like sequence
Fig. 1. Creation of recombinant adenoviruses containing SP-A:hGH fusion genes and transfection of type II cells in primary culture.
Fusion genes were constructed comprised of various amounts of 5P-£anking DNA and 20 bp of the ¢rst exon from the human, rabbit
or baboon SP-A genes linked to the human growth hormone (hGH) structural gene, as reporter (SP-A:hGH). These fusion genes
were incorporated into the genome of the replication-defective human adenovirus, Ad5, and introduced into primary cultures of hu-
man or rat type II cells by infection. Fusion gene expression was analyzed by radioimmunoassay of hGH secreted into the culture me-
dium.
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(CRESPÿA) [33^35], a GT box (GTSPÿA) [51] and
several thyroid transcription factor-1 (TTF-1)-bind-
ing elements (TBE) [52] (Fig. 2). Mutagenesis of any
one of these elements has a marked e¡ect to reduce
basal and cyclic AMP induction of SP-A promoter
activity. CRESPÿA, TBE and GTSPÿA are highly con-
served with regard to sequence and position in the
5P-£anking regions of all of the SP-A genes thus far
characterized (only exception is the position of
CRESPÿA in the 5P-£anking sequence of the rat SP-
A gene [53]) (Fig. 2). Although the PBE at 387 bp
appears unique to the rabbit SP-A gene 5P-£anking
region, we found that proximal 5P-£anking sequences
of the human and baboon SP-A2 genes compete with
rabbit type II cell nuclear proteins for binding to the
PBE (E. Gao, C.R. Mendelson, unpublished data),
suggesting the presence of related element(s) within
SP-A 5P-£anking regions of other species. In the fol-
lowing sections, we will review our studies to char-
acterize these response elements and their binding
proteins, and provide some insight into the mecha-
nisms whereby these factors mediate developmental,
type II cell-speci¢c and cyclic AMP regulation of SP-
A gene expression.
4.1.1. A 300^400 bp sequence within the 5P-£anking
regions of the human, baboon and rabbit SP-A
genes mediates cyclic AMP-responsive
expression in a type II cell-speci¢c manner
In deletion mapping studies to functionally de¢ne
the regulatory regions of the human SP-A2 gene, we
observed that fusion genes containing 296 bp of 5P-
£anking DNA manifested maximal levels of basal
and cyclic AMP-induced expression in transfected
human fetal lung type II cells (Fig. 3A) [35]. In
type II cells transfected with hSP-A23231 :hGH fusion
genes, basal expression was markedly reduced to lev-
els comparable to those of a fusion gene containing
only 62 bp of hSP-A2 5P-£anking DNA, and no cy-
clic AMP induction was evident. This suggests the
presence of a cyclic AMP-response element between
3231 and 3296 bp [35]. Basal and cyclic-AMP-in-
duced expression of hSP-A2:hGH fusion genes con-
taining v426 bp of hSP-A2 5P-£anking sequence was
considerably reduced as compared to that of the
hSP-A23296 :hGH fusion gene construct, suggesting
the presence of an upstream silencer element(s). Sim-
ilar results were obtained in deletion mapping studies
of the baboon SP-A2 5P-£anking region, in which
maximal basal and cyclic AMP-induced expression
was observed with bSP-A2:hGH fusion genes con-
taining 3255 bp of bSP-A2 5P-£anking sequence [52].
The ¢ndings that Bt2cAMP markedly induced ex-
pression of hSP-A23296 :hGH fusion genes in type
II cells in primary culture, but not in lung adenocar-
cinoma cell lines of presumed type II (A549) or Clara
(H441) cell origin, or in other cell types (H4IIE hep-
atoma, Y1 adrenal cortical tumor) (Fig. 3B) [35],
suggest a role of type II cell-speci¢c transcription
factors in cyclic AMP induction of SP-A gene expres-
sion.
In studies to functionally de¢ne the genomic re-
Fig. 2. Schematic diagram of the SP-A structural gene and 5P-£anking region containing response elements conserved among various
species. Sequences and positions of the CRESPÿA, TTF-1, E box, GT box elements relative to the start sites of transcription of the
SP-A genes of various species are shown. The position of the TATA box and the start of transcription (denoted by the arrow) are in-
dicated. Reprinted in a modi¢ed form with permission from Young et al. [51].
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gions that regulate basal and cyclic AMP induction
of rabbit SP-A promoter activity in type II cells, we
found that rabbit SP-A 5P-£anking sequences be-
tween 347 and 3378 bp are essential for cyclic
AMP induction of SP-A promoter activity in a
type II cell-speci¢c manner, whereas sequences be-
tween 3378 and 3991 bp enhanced overall levels
of basal and cyclic AMP-induced expression (Fig.
4) [33]. As compared to the human and baboon
SP-A2 genes, the rabbit SP-A gene does not appear
to have upstream silencer elements (Fig. 4).
4.1.2. A CRE-like sequence (CRESPÿA) is required
for cyclic AMP induction of SP-A promoter
activity in transfected type II cells and may
serve as a binding site for a member of the
nuclear receptor family
As discussed above, 5P-£anking sequences within
3296 bp, 3255 bp and 3378 bp upstream from
the human, baboon and rabbit SP-A genes, respec-
tively, are required for cyclic AMP induction of
SP-A promoter activity in transfected type II cells.
Furthermore in the hSP-A2 deletion mapping stud-
ies, a cyclic AMP-responsive region was localized to
sequences between 3231 and 3296 bp (Fig. 3A).
Based on sequence comparison of the SP-A 5P-£ank-
ing regions with binding site consensus sequences of
known transcription factors, a conserved sequence
(TGACCTC/TA) was identi¢ed in the 5P-£anking re-
gions of the human and baboon SP-A2 genes at
3242 bp and in the rabbit SP-A gene at 3261 bp
Fig. 3. Expression of an hSP-A2:hGH fusion gene containing
v296 bp of hSP-A2 5P-£anking DNA is stimulated by cyclic
AMP in a type II cell-speci¢c manner. (A) Human fetal type II
cells in primary culture were infected with recombinant adeno-
viruses containing hSP-A2:hGH fusion genes containing +20
bp of exon I and 347, 362, 3231, 3296, 3425, 3525 or
31500 bp of 5P-£anking DNA from the hSP-A2 gene linked to
the hGH structural gene as reporter (depicted in diagrammatic
form on the left margin). After infection, the cells were incu-
bated for up to 5 days in serum-free medium in the absence
(Control) or presence of Bt2cAMP (1 mM). Culture media were
harvested and replaced every 24 h; hGH concentrations shown
are in media collected on day 5 of culture. Values are the
mean þ S.E.M. of data from three independent experiments,
each conducted in triplicate. (B) Primary cultures of human fe-
tal type II cells, as well as A549, NCI-H441, Y1 and H4IIE
cells were infected with recombinant adenoviruses containing
the SP-A23296 :hGH fusion gene construct and incubated in the
absence or presence of Bt2cAMP for 5 days. Shown are levels
of hGH secreted by these cells over a 24 h period between days
4 and 5 of incubation. Values are the mean þ S.E.M. of data
from two independent experiments, each conducted in triplicate
(n = 6). Reprinted in a modi¢ed form with permission from
Young et al. [35].
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(Fig. 2). We named this sequence CRESPÿA because
of its similarity to the palindromic consensus cyclic
AMP-response element (CREpal, TGACGTCA),
which is known to bind the basic leucine zipper tran-
scription factor, cyclic AMP-response element-bind-
ing protein (CREB), as a homodimer [54].
To analyze the functional role of CRESPÿA in cy-
clic AMP induction of human SP-A2 promoter ac-
tivity, we observed that mutagenesis of CRESPÿA in
the context of the hSP-A23296 :hGH fusion gene
(3296CREmut) caused a marked reduction in basal
and loss of cyclic AMP-induced expression (Fig. 5)
[35]. Expression of the hSP-A23296CREmut :hGH fu-
sion gene was reduced to levels comparable to those
of fusion genes containing 62 bp of hSP-A2 5P-£ank-
ing sequence (Fig. 5). In studies of the rabbit SP-A
gene, mutagenesis of CRESPÿA at 3261 bp also re-
sulted in a marked reduction of basal and cyclic
AMP induced expression of rabbit SP-A3991 :hGH
fusion genes in transfected type II cells [34]. These
¢ndings indicate that CRESPÿA serves an important
role in basal and cyclic AMP induction of SP-A pro-
moter activity in type II cells.
To begin to characterize the transcription factor(s)
that bind to CRESPÿA, UV crosslinking analysis was
performed. By use of nuclear extracts from midges-
tation human fetal lung cultured in the presence of
Bt2cAMP and radiolabeled CRESPÿA as a probe,
speci¢c binding of proteins of approx. 50 and 36
kDa was observed [35]. On the other hand, when
CREpal, known to bind the transcription factor
CREB (MrW43 000), was used as a probe, binding
of only an approx. 43 kDa protein was evident. Fur-
thermore, in Southwestern blotting assays using the
radiolabeled CREpal as a probe, a binding protein of
approx. 43 kDa again was evident; however, no
binding species were detectable when radiolabeled
CRESPÿA was used as a probe. Since Southwestern
Fig. 4. Rabbit SP-A 5P-£anking sequences between 347 and
3378 bp containing the PBE (at 387 bp) mediate cyclic AMP
induction of SP-A promoter activity in type II cells, whereas
5P-£anking sequences between 3378 and 3990 bp containing
the DBE (at 3986 bp) enhance overall levels of expression. Rat
type II cells were infected with recombinant adenoviruses con-
taining SP-A:hGH fusion genes comprised of 991, 378 or 47 bp
of 5P-£anking sequence from the rabbit SP-A gene. After infec-
tion, the cells were incubated in serum-free medium in the ab-
sence (Control) or presence of Bt2cAMP (1 mM) for up to 5
days. Expression of an SP-A3976 :hGH fusion gene, which lacks
the DBE, and an SP-A3991PBE3 :hGH fusion gene containing a
mutation in the PBE, were also analyzed. Culture media were
harvested and replaced daily. Shown are the levels of hGH that
accumulated in the medium over a 24 h period between days 4
and 5 of culture. Values are the mean þ S.E.M. of data from
three independent experiments each conducted in triplicate. Re-
printed in a modi¢ed form with permission from Alcorn et al.
[33].
Fig. 5. CRESPÿA and the GT box of the hSP-A2 gene are es-
sential for cyclic AMP induction of SP-A promoter activity in
type II cells. Human type II cells in primary culture were in-
fected with recombinant adenoviruses containing hSP-A2:hGH
fusion genes comprised of 296, 62 and 47 bp of 5P-£anking se-
quence from the human SP-A2 gene, or with hSP-A23296 :hGH
containing mutations in CRESPÿA (3296CREmut) or GTSPÿA
(3296GTmut) and incubated for 5 days in the absence (Con-
trol) or presence of Bt2cAMP. Shown are the levels of hGH
that accumulated in the medium over a 24 h period between
days 4 and 5 of culture. Values are the means þ S.E.M. of data
from two independent experiments, each conducted in triplicate.
Reprinted with permission from Young et al. [51].
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blotting precludes the formation of heteromeric bind-
ing complexes, these ¢ndings together with those of
UV crosslinking suggest that a unique heteromeric
complex that does not include CREB binds to
CRESPÿA [35].
The inability of CREB or related basic leucine
zipper transcription factors to bind CRESPÿA was
further supported by the ¢ndings of EMSA, which
indicated that antibodies to CREB and related bZIP
transcription factors (CREM, ATF-1) failed to
supershift the complex of lung nuclear proteins
bound to CRESPÿA, whereas a supershift was evident
using CREpal as a probe. Furthermore, bacterially
expressed CREB failed to bind to CRESPÿA, in con-
trast to its ability to bind to CREpal [34]. By com-
petition EMSA using mutagenized CRESPÿA oligo-
nucleotides, the critical protein-binding nucleotides
in CRESPÿA were found to constitute a hexameric
element, TGACCT, which corresponds to a half-
site for binding members of the nuclear receptor
superfamily [34]. Since the TGACCT motif is highly
conserved and present as a single site in the SP-A
genes of a variety of species, we propose that a mem-
ber of the nuclear receptor superfamily may bind to
this element as a monomer.
4.1.3. A GT box which is crucial for basal and cyclic
AMP induction of SP-A promoter activity,
binds transcription factor Sp1 and related
proteins
As noted above, a GT box (GTSPÿA ; GGG-
GTGGGG) at 361 bp within the 5P-£anking region
of the human SP-A2 gene is highly conserved in se-
quence and position in the SP-A gene 5P-£anking
regions of other species (Fig. 2). To analyze the
functional role of GTSPÿA in basal and cyclic AMP
induced expression of the hSP-A2 gene, this element
was mutated in the context of the hSP-A23296 :hGH
fusion gene (3296GTmut) and transfected into hu-
man type II cells. As can be seen in Fig. 5, this
mutation caused a marked reduction of basal and
abolished cyclic AMP-induced expression [51]. Ex-
pression of hSP-A23296GTmut :hGH was similar to
that of the minimal promoter construct, hSP-
A2347 :hGH, which lacks the GTSPÿA sequence and
includes only the TATA motif. Basal expression of
the hSP-A2362 :hGH construct, which just includes
GTSPÿA, was s 3-fold higher than the 347 bp min-
imal promoter construct; however, no cyclic AMP
induction of hSP-A2362 :hGH was evident (Fig. 5).
These ¢ndings indicate that GTSPÿA is necessary but
not su⁄cient for cyclic AMP induction of SP-A2
promoter activity in type II cells.
By EMSA, it was observed that nuclear proteins
isolated from primary cultures of type II cells bound
the GT box as ¢ve speci¢c complexes. By contrast,
nuclear proteins isolated from lung ¢broblasts dis-
played markedly reduced binding activity. Competi-
tion and supershift EMSA indicated that the ubiqui-
tously expressed transcription factor Sp1, a GC box-
binding protein of approx. 100 kDa, is a component
of the complex of proteins that bind the GT box of
hSP-A2 [51]. The ¢nding that only two of the ¢ve
GT box-binding complexes were supershifted by in-
cubation with Sp1 antibody suggests that a factor(s)
in type II cell nuclear extracts that is distinct from
Sp1 also interacts with the GT box. By UV cross-
linking and SDS/PAGE/EMSA analysis, we have
identi¢ed an approx. 55 kDa GT box-binding factor
in type II cell nuclear proteins that preferentially
binds the GT box of SP-A2 over the consensus Sp1
GC box sequence. This 55 kDa factor was able to
bind the GT box independently of Sp1 [51]. Sp1 is a
ubiquitously expressed member of the Kru«ppel fam-
ily of zinc ¢nger-containing transcription factors.
Several novel proteins belonging to the Kru«ppel fam-
ily have recently been identi¢ed, which manifest sig-
ni¢cantly higher binding activity towards the GT/CA
box than does Sp1 [55]. We suggest that the 55 kDa
factor that interacts with the GT box of SP-A2 may
be a new member of this protein family.
4.1.4. An E box sequence (PBE) is essential for basal
and cyclic AMP-induced expression of rabbit
SP-A promoter activity in type II cells
As shown in Fig. 4, functional mapping of the 5P-
£anking sequence of the rabbit SP-A gene indicated
that sequences between 347 and 3378 bp are re-
quired for cyclic AMP induction of SP-A promoter
activity, whereas sequences between 3378 and 3991
bp serve as enhancers of basal and cyclic AMP-in-
duced expression. By use of EMSA, two lung nuclear
protein-binding sites, termed distal binding element
(DBE, 3986 to 3977 bp) and proximal binding ele-
ment (PBE, 387 to 370 bp), were identi¢ed. DBE
and PBE have related core E box-like sequences
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(DBE: CACGTG; PBE: CTCGTG) [49] and com-
pete for binding to lung nuclear proteins. Binding
activity for DBE and PBE was found to be greatly
enriched in nuclear extracts of lung type II cells as
compared to nuclear extracts from whole lung tissue
[49].
To assess the functional role of the DBE and PBE
in the regulation of SP-A promoter activity, expres-
sion of an SP-A3976DBE3 :hGH fusion gene, which
lacks the DBE, and an SP-A3991PBE3 :hGH fusion
gene containing a mutation in the PBE, were an-
alyzed in transfected type II cells (Fig. 4). Basal
and cyclic AMP-induced expression of SP-
A3976DBE3 :hGH was reduced to levels comparable
to those observed with SP-A3378 :hGH fusion genes.
The ¢nding that expression of SP-A3976 :hGH was
stimulated approx. 15-fold by Bt2cAMP treatment
suggests that the DBE serves as a general, rather
than as a speci¢c enhancer of cyclic AMP regulated
expression. On the other hand, mutagenesis of the
PBE sequence in the context of the SP-A3991 :hGH
fusion gene construct (SP-A3991PBE3 :hGH) caused
a marked reduction of basal expression and a loss of
cyclic AMP stimulated expression to levels compara-
ble to those of the SP-A347 :hGH (Fig. 4) [49]. The
¢ndings of type II cell transfection studies, as well as
those using EMSA, suggest that the DBE and PBE
act as enhancers that interact with the same or re-
lated trans-acting factors and serve important roles
in type II cell-speci¢c, cyclic AMP-mediated regula-
tion of SP-A gene expression [49]. It is apparent that
the PBE serves a more critical role in basal and cyclic
AMP regulation of SP-A promoter activity than does
the DBE. Whether this is due to its proximity to the
promoter, or its interaction with other transcription
factors bound to adjacent response elements, remains
to be determined. Interestingly, the position of the
PBE coincides approximately with the location of a
DNase I hypersensitive site at approx. 3100 bp,
which was found to be present in nuclei from rabbit
lung several days prior to the time of initiation of
SP-A gene transcription on day 24, but not in nuclei
from liver or kidney tissues [5].
4.1.4.1. DBE and PBE bind the basic helix-loop-
helix-zipper transcription factor USF1, which is devel-
opmentally regulated and expressed in a type II cell-
speci¢c manner in fetal rabbit lung. To characterize
transcription factors that bind to these E box motifs,
radiolabeled PBE was used to screen a rabbit fetal
lung cDNA expression library; cDNA inserts were
isolated encoding two alternatively spliced forms of
the basic-helix-loop-helix-zipper transcription factor
upstream stimulatory factor 1 (rUSF1a and b) [50].
By use of reverse transcriptase PCR, rUSF1a and 1b
mRNAs were identi¢ed in fetal rabbit lung and other
tissues. We found that USF1 gene expression is de-
velopmentally regulated in fetal rabbit lung. Interest-
ingly, the levels of rUSF1 mRNAs reach a peak in
fetal rabbit lung at 23 days gestation, in concert with
the time of initiation of SP-A gene transcription (Fig.
6A) [50]. Binding complexes of nuclear proteins from
fetal rabbit lung tissue or type II cells with radio-
labeled DBE or PBE were supershifted by addition
of anti-rUSF1 IgG (Fig. 6B). USF1-binding activity
was found to be highly enriched in type II cells as
compared with lung ¢broblasts (Fig. 6B). The ¢nding
that overexpression of rUSF1s in A549 adenocarci-
noma cells positively regulated SP-A promoter activ-
ity of co-transfected reporter gene constructs sug-
gests that rUSF1 may serve a key role in the
regulation of SP-A gene expression in pulmonary
type II cells [50].
4.1.5. TBEs are required for cyclic AMP induction of
SP-A promoter activity in type II cells; binding
and transcriptional activation of TTF-1 is
increased by cyclic AMP-dependent protein
kinase (PKA)
TTF-1 is a homeodomain transcription factor ex-
pressed selectively in developing thyroid, diencepha-
lon and lung epithelium from the earliest stages of
organogenesis [56]. Mice rendered TTF-1 de¢cient by
gene targeting, lacked thyroid, anterior pituitary and
lung parenchyma [57]. By mutagenesis, it was found
that the TTF-1 sites in the mouse SP-A gene 5P-
£anking sequence were required for basal expression
of the SP-A promoter in transfected mouse lung epi-
thelial cells [58]. We have identi¢ed three TBEs with-
in 255 bp of the 5P-£anking region of the baboon SP-
A2 gene (Fig. 7) [52]. One of these elements (TBE1)
at 3172 bp is highly conserved with regard to posi-
tion and sequence among all of the SP-A genes thus
far characterized (Fig. 2). In type II cell transfection
experiments, we observed that mutagenesis of TBE1
had a more pronounced e¡ect to reduce basal and
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cyclic AMP induced expression than mutagenesis of
either TBE2 or TBE3 (Fig. 7) [52].
In studies to de¢ne the mechanism(s) whereby
TTF-1 mediates cyclic AMP induction of SP-A
gene expression in type II cells, we observed that
TTF-1 DNA-binding activity of type II cell nuclear
extracts was increased by cyclic AMP treatment. By
contrast, nuclear protein-binding activities for
CRESPÿA and the GT box were una¡ected by cyclic
AMP (Fig. 8) [52]. These ¢ndings indicate for the
¢rst time that cyclic AMP speci¢cally increases
TTF-1-binding activity in type II cells. Our ¢ndings
that the levels of immunoreactive TTF-1 in nuclear
extracts, as well as the rate of incorporation of
[35S]methionine into immunoisolated TTF-1 were un-
a¡ected by cyclic AMP treatment of type II cells [52],
suggest that cyclic AMP induction of TTF-1-binding
activity is not mediated by changes in its nuclear
localization or expression. In association with its ef-
fect to stimulate TTF-1 DNA-binding activity, we
observed that cyclic AMP treatment markedly in-
creased the rate of 32P-phosphate incorporation
into immunoisolated TTF-1 [52]. The ¢nding that
phosphatase treatment e¡ectively abolished the cyclic
AMP induction of TTF-1 DNA-binding activity in-
dicates that cyclic AMP-induced TTF-1 phosphory-
lation mediates the increase in binding activity for
TBEs within the bSP-A2 5P-£anking sequence [52].
A PKA phosphorylation site near the N terminus
(Thr9) of TTF-1 was identi¢ed and found to be es-
Fig. 6. USF1 mRNA levels are developmentally regulated and
type II cell-speci¢c in fetal rabbit lung. (A) Total RNAs iso-
lated from lung tissues of fetal rabbits of 21^28 days gestational
age and from neonates (N) were used as templates for reverse
transcription of rUSF1 cDNAs. cDNAs were ampli¢ed by PCR
in the presence of a competitive internal standard control tem-
plate (CIS), a non-homologous DNA fragment containing the
rUSF1 primer templates. PCR products were resolved on an
agarose gel. An autoradiograph of the gel (upper panel) was
scanned; arbitrary units of USF1 mRNA are expressed relative
to those of CIS (lower panel). (B) 32P-Labeled PBE was incu-
bated with nuclear proteins isolated from fetal rabbit lung ¢-
broblasts (Fb) or type II cells (TII), followed by incubation in
the absence or presence of anti-rUSF1 IgG, and by electropho-
resis and autoradiography. F, free probe; C, DNA-protein
complexes; S, antibody supershift of DNA-protein complexes
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sential for PKA activation of the SP-B promoter in
H441 cells [59].
To analyze e¡ects of PKA on TTF-1 transcription-
al activity, A549 cells, a lung adenocarcinoma cell
line which lacks TTF-1, were co-transfected with a
bSP-A23255 :hGH fusion gene (which contains three
TBEs), and with expression vectors for TTF-1, and
for PKA catalytic (PKA-cat) subunits K and L (Fig.
9A). Co-transfection of TTF-1 caused an induction
of bSP-A2 promoter activity (Fig. 9A). The response
to TTF-1 was increased further by co-transfection of
PKA catalytic subunits. The ¢nding that PKA-cat
had no e¡ect to increase bSP-A2 promoter activity
in the absence of co-transfected TTF-1 and that mu-
tation of the major TTF-1-binding site abolished
PKA induction of TTF-1 transcriptional activity
(data not shown) [52] suggests that the e¡ect of
PKA to induce bSP-A2 gene expression is mediated,
in part, through TTF-1. We have also observed that
the TTF-1 induction of bSP-A23255 :hGH fusion
gene expression in the absence of co-transfected
PKA-cat was prevented by co-transfection of a dom-
inant negative form of PKA RIK [52]. This suggests
that the inductive e¡ect of TTF-1 on bSP-A2 pro-
moter activity in A549 cells is dependent upon phos-
phorylation by endogenous PKA. To further sub-
stantiate the role of TTF-1 in PKA induction of
SP-A promoter activity, A549 cells transfected with
a reporter gene containing three tandem TBEs fused
upstream from the bSP-A2 gene TATA box and
transcription initiation site (TBE3SP-A2:hGH) were
co-transfected with PKA-cat and TTF-1 expression
vectors (Fig. 9B). The ¢nding that PKA-cat en-
hanced transactivation of TBE3SP-A:hGH by co-
transfected TTF-1 indicates that the e¡ect of PKA
to increase SP-A promoter activity is mediated
speci¢cally by TTF-1 binding to TBEs. These ¢nd-
ings, together with those that indicate that cyclic
AMP speci¢cally increases TTF-1-binding activity
in type II cells, suggest that TTF-1 is the cyclic
Fig. 7. TTF-1-binding elements (TBE) mediate basal and cyclic AMP induction bSP-A2 promoter activity in type II cells. (A) Sche-
matic diagram of the bSP-A2 gene 5P-£anking region (3255 to 40 bp) showing the locations and core sequences of three TBEs and of
CRESPÿA and the GT box. (B) Expression of bSP-A23255 :hGH fusion genes with and without mutations in TBE1, TBE2 and TBE3
(M1, M2, M3, respectively) in rat fetal lung type II cells maintained in the absence or presence of Bt2cAMP. After infection, the cells
were incubated for up to 5 days in serum-free medium in the absence or presence of Bt2cAMP. Culture media were harvested and re-
placed every 24 h. Shown are the concentrations of hGH that accumulated in the medium between days 4 and 5 of culture. Values
are means þ S.E. of data from two independent experiments, each conducted in triplicate. Reprinted with permission from Li et al.
[52].
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AMP-responsive transcription factor in lung type II
cells.
5. Concluding remarks and future perspectives
In studies to de¢ne the regulatory elements of the
SP-A gene, four di¡erent response elements have
been identi¢ed within a 400 bp region just upstream
from the transcription start site that mediate high
basal and cyclic AMP induction of SP-A promoter
activity in transfected type II cells. These include a
CRE-like sequence which may bind a member of the
nuclear receptor superfamily (CRESPÿA), several
TTF-1-binding sites, an E box which binds the tran-
Fig. 9. PKA increases TTF-1 transcriptional activity in transfected A549 cells. A549 cells were co-transfected either with bSP-
A23255 :hGH (A) or with a (TBE)3SP-A2:hGH fusion gene comprised of three tandem copies of TBE1 fused to a basal bSP-A2 pro-
moter linked to hGH, as reporter (B) in the absence or presence of a TTF-1 expression vector (pCMV5/TTF-1) or pCMV5 empty
vector, and either with expression vectors for PKA catalytic subunit-K (RSV/PKA-cat-K), PKA catalytic subunit L (RSV/PKA-cat-L),
a mutated form of PKA catalytic subunit L (RSV/PKA-cat-Lm), or the corresponding empty vector pRSV, plus internal control,
RSV-Lgal. Shown are the levels of hGH secreted into the medium over a 24 h period, 48 h after transfection. Data are the means þ
S.E.M. from two independent experiments, each conducted in triplicate, normalized to L-galactosidase activity. Reprinted with permis-
sion from Li et al. [52].
Fig. 8. Cyclic AMP treatment of type II cells increases binding
activity of nuclear proteins for the TBE1, but not for
CRESPÿA, or the GT box. Nuclear proteins from human fetal
type II cells cultured for 5 days in control or Bt2cAMP (1 mM)-
containing medium were incubated with 32P-labeled TBE1,
CRESPÿA and GT box-containing oligonucleotides and analyzed
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scription factor USF1, and a GT box which binds
Sp1 along with other proteins that may be tissue-
selective members of the Kru«ppel family of transcrip-
tion factors. Each of these elements is crucial for
basal and cyclic AMP induction of expression of
the rabbit, human and baboon SP-A genes in trans-
fected type II cells. We recently have found that cy-
clic AMP-responsive expression of the SP-A gene is
mediated by a PKA-catalyzed increase in TTF-1
phosphorylation, which results in increased DNA-
binding and transcriptional activity. It, therefore, ap-
pears that the PKA-mediated increase in TTF-1
phosphorylation and DNA-binding activity may
constitute the primary mechanism for cyclic AMP
induction of SP-A gene expression. We suggest that
the increase in TTF-1 phosphorylation and DNA-
binding activity may facilitate its interactions with
transcription factors bound to the other cis-acting
elements found to be essential for cyclic AMP induc-
tion of SP-A promoter activity, as well as with co-
activators and components of the basal transcription
machinery (Fig. 10). This unique complement of
transcription factors and coactivators serves to acti-
vate expression of the SP-A gene in a lung cell-spe-
ci¢c and developmentally timed manner. Future
studies include the isolation and characterization of
the transcription factors that bind to these critical
response elements and analysis of the mechanisms
whereby they act cooperatively to regulate type II
cell-speci¢c, developmental and hormonal regulation
of SP-A gene expression in fetal lung.
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Fig. 10. Proposed mechanism for cyclic AMP induction of SP-A gene expression in type II cells. Binding of regulatory hormone to its
receptor results in activation of adenylyl cyclase, increased cyclic AMP formation and activation of PKA tethered to the nuclear mem-
brane by a speci¢c A-kinase anchor protein (AKAP). Entry of activated PKA catalytic subunit (C) into the nucleus results in in-
creased phosphorylation of TTF-1 and its enhanced binding to TBEs. This, in turn, results in the interaction of TTF-1 with transcrip-
tion factors bound to CRESPÿA, E box and GT box sequences. Certain of these factors have been found to be developmentally
regulated in fetal lung (e.g. USF1 bound to PBE) and selectively expressed in type II cells (USF1 and GT box-binding proteins (which
include Sp1)). Cooperative interaction of these transcription factors with each other and putative co-activators leads to induction of
SP-A promoter activity and increased SP-A gene transcription.
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